跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,299 条关于
“PB-223 ADC”
全部
7,299
临床试验
3,775
药物
1,856
机构
77
资讯
1,591
7个月前
Precision Biologics Presents Preclinical Data on Novel PB-223 ADC Targeting Truncated Core-2 Glycans in Solid Tumors
12个月前
Precision Biologics Reports Promising Efficacy Data for Novel Ovarian Cancer ADC PB-vcMMAE-5
2年前
Radium-223 Plus Enzalutamide Extends Survival in Metastatic Castration-Resistant Prostate Cancer
2年前
Bayer's Radium-223 Dichloride Expands Treatment Horizons for Metastatic Prostate Cancer
去年
PEACE III Trial: Radium-223 Plus Enzalutamide Significantly Improves Outcomes in mCRPC
去年
Artbio Raises $132 Million Series B to Advance Lead-212 Radiopharmaceutical for Prostate Cancer
去年
PEACE-3 Trial: Enzalutamide and Radium-223 Combination Shows Promise in mCRPC
2年前
Radium-223 Plus Enzalutamide Improves Survival in mCRPC with Bone Metastases
11个月前
Ferrer Completes Early Enrollment for Phase II PSP Trial Testing Novel OGA Inhibitor FNP-223
2年前
Enzalutamide and Radium-223 Combo Improves Survival in Metastatic Prostate Cancer
第 1 页,共 160 页
上一页
下一页